重组人促甲状腺激素（rhTSH），来源于中国仓鼠卵巢（CHO）细胞，由美国Sanofi Genezyme公司研发，于1998年12月在FDA批准上市，2000年3月，在欧洲上市，主要用于甲状腺癌的辅助诊断和辅助治疗。目前在中国尚无上市产品。由苏州泽璟生物制药股份有限公司研制的rhTSH，其药学性质与原研产品基本一致。
rhTSH常见不良反应（≥1%）包括恶心、头痛、疲乏、呕吐、头晕、虚弱。其它不良反应还包括：
（1）一过性流感样综合征，主要症状为发热（38°C），寒战，肌痛/关节痛，疲乏/虚弱，头痛等，一般在48小时内消失。
（2）过敏反应：包括荨麻疹，皮疹，瘙痒，脸红，呼吸道症状等。
（3）注射部位反应：包括疼痛，结节性红斑，瘀斑和瘙痒。
Nice post. I learn something totally new and challenging on websites
Great information shared.. really enjoyed reading this post thank you author for sharing this post .. appreciated
I’m often to blogging and i really appreciate your content. The article has actually peaks my interest. I’m going to bookmark your web site and maintain checking for brand spanking new information.
This is my first time pay a quick visit at here and i am really happy to read everthing at one place
Very well presented. Every quote was awesome and thanks for sharing the content. Keep sharing and keep motivating others.